DIA475.35+3.14 0.67%
SPX6,875.16+83.47 1.23%
IXIC23,637.46+432.59 1.86%

Haleon Partners With Salesforce To Enhance Global Engagement With Pharmacies Using AI-Powered Solutions

Benzinga·10/08/2025 14:26:58
Listen to the news

Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide.

Haleon has chosen Salesforce Life Sciences Cloud for Customer Engagement, Data Cloud, and Agentforce to support its 4,500-strong sales force globally. The AI-powered solution will enable the global consumer healthcare company to have more productive customer interactions, deepening its relationships with pharmacists and healthcare professionals around the world. This should serve to benefit millions of consumers globally by giving more people better access to everyday healthcare products.

With Salesforce, Haleon's sales representatives will spend less time on administrative tasks and have access to data-driven insights on consumer demographics, shopping trends, and point-of-sale marketing. This will enable Haleon's sales representatives to focus their efforts on value-add activities such as bespoke activation plans for their customers.

Additionally, Haleon, maker of category leading brands like Sensodyne, Voltaren, and Centrum, will serve as a design partner for Salesforce Life Sciences Cloud for Customer Engagement. In this role, Haleon will influence the development of Salesforce's life sciences solutions to further address the specific needs of the consumer health industry, including by supporting product availability, shelf-life management, promotions, and inventory management across global retail and online channels.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.